Mccormick & CO INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
McCormick & Company reported a 16.7% increase in second-quarter net sales and reaffirmed its full-year 2026 financial outlook.
NYSE
McCormick & Company, Inc. announced the appointment of Cindy Hoots, former Chief Digital Officer and CIO of AstraZeneca PLC, to its Board of Directors, effective June 1, 2026.
NYSE
McCormick & Company appoints Andrew Foust as Chief Integration Officer to lead the Unilever foods business combination.
NYSE
McCormick & Company has entered into a definitive agreement to acquire Unilever's global foods business in a transaction valued at $15.7 billion.
NYSE
McCormick & Company, Inc. held its Annual Meeting of Stockholders on April 1, 2026, where directors were elected, the appointment of Ernst & Young LLP as independent auditor was ratified, and executive compensation was approved in an advisory vote.
NYSE
McCormick & Company reported strong first quarter 2026 financial results, driven by the McCormick de Mexico acquisition and organic growth, while reaffirming its full fiscal year 2026 outlook.
NYSE
McCormick & Company, Incorporated filed a legal opinion confirming the validity of shares to be offered under its Investor Services Plan.
NYSE
McCormick & Company successfully issued $500 million in 4.150% Notes due 2029 to redeem existing 0.90% Notes maturing in February 2026.
NYSE
McCormick & Company announced strong financial results for fiscal year 2025, including increased sales and adjusted earnings per share, and provided a positive outlook for 2026 driven by strategic acquisitions and efficiency programs.
NYSE
McCormick & Company announces the appointment of two new directors, Gavin Hattersley and Rick Dierker, to its Board, effective February 1, 2026, alongside the planned retirements of two long-serving members.
NYSE
McCormick & Company completed the acquisition of an additional 25% ownership in McCormick de Mexico from Grupo Herdez for $750 million, increasing its stake to 75%.
NYSE
McCormick & Company reported a 3% net sales increase in the third quarter of fiscal 2025, reaffirming sales growth outlook while updating profitability guidance due to rising commodity costs and tariffs.
NYSE
McCormick & Company announced a definitive agreement to acquire an additional 25% ownership in McCormick de Mexico for $750 million, increasing its stake to 75% and expanding its flavor leadership in the region.
NYSE
McCormick & Company, Inc. announced strong second quarter 2025 financial results, including a 1% increase in net sales and a 10% rise in adjusted operating income, while reaffirming its full fiscal year 2025 outlook despite ongoing tariff impacts.
NYSE
McCormick & Company files an amendment to its original 8-K report to correct submission errors in the voting results of the 2025 Annual Meeting of Stockholders.
NYSE
McCormick & Company held its annual meeting on March 26, 2025, where stockholders elected directors, ratified the appointment of Ernst & Young LLP as the independent auditor, and approved executive compensation in an advisory vote.
NYSE
McCormick & Company reports first quarter results in line with expectations and reaffirms its fiscal year 2025 outlook.
NYSE
Patricia Little, a director at McCormick & Co., has announced her intention to retire from the board and will not seek re-election at the upcoming annual stockholders meeting.
NYSE
McCormick & Company reported a 3% sales increase for the fourth quarter of 2024 and a 1% increase for the full fiscal year, driven by volume and pricing, while also providing a 2025 financial outlook.
NYSE
McCormick & Company's Executive Chairman, Lawrence Kurzius, will retire, with President and CEO Brendan Foley appointed as the new Chairman effective January 1, 2025.
NYSE
McCormick & Company has successfully completed the issuance of $500 million in 4.700% notes due in 2034, with the proceeds intended for debt repayment and general corporate purposes.
NYSE
McCormick & Company reported third-quarter sales comparable to the previous year, with a notable increase in operating income and reaffirmed its fiscal year 2024 outlook.
NYSE
McCormick & Company reported a slight sales decline in the second quarter, but reaffirmed its full-year 2024 outlook, citing strong performance in the Consumer segment and cost-saving initiatives.
NYSE
McCormick & Company has appointed Marcos Gabriel as its new Executive Vice President and Chief Financial Officer, effective December 1, 2024, succeeding Mike Smith who will retire in February 2025.
NYSE
McCormick & Company has appointed Valarie Sheppard, former Executive Vice President, Controller and Treasurer of Procter & Gamble, to its Board of Directors, effective June 1, 2024.
NYSE
McCormick & Company held its annual meeting on March 27, 2024, where stockholders elected twelve directors, ratified the appointment of Ernst & Young LLP as the independent auditor, and approved executive compensation in an advisory vote.
NYSE
McCormick & Company reported a strong first quarter with a 3% sales increase and reaffirmed its fiscal year 2024 outlook.
NYSE
McCormick & Company reported a 5% sales increase for fiscal year 2023, with a cautious outlook for 2024 due to consumer uncertainty.
NYSE
McCormick & Company has appointed Terry Thomas, Chief Growth Officer of Flowers Foods, to its Board of Directors, effective January 23, 2024.
NYSE
Dr. Freeman A. Hrabowski, III, will retire from the McCormick & Company Board of Directors at the next annual stockholders meeting.